Business
Press Release Apr 10 2021
Natco Pharma Limited has informed the Exchange regarding a press release dated April 10, 2021, titled "NATCO receives tentative approval for Ibrutinib tablets (generic for IMBRUVICA ��) ANDA in the US market".
About this update from Natco Pharma Limited
[{"type":"text","content":" Natco Pharma Limited has informed the Exchange regarding a press release dated April 10, 2021, titled \"NATCO receives tentative approval for Ibrutinib tablets (generic for IMBRUVICA ��) ANDA in the US market\". View Attachment","length":357,"tagName":"div"}]